Report

TABLE OF CONTENTS
1 INTRODUCTION 83
1.1 OBJECTIVES OF THE STUDY 83
1.2 MARKET DEFINITION 83
1.3 OVERVIEW OF EUROPE ENDOSCOPIC HEMOSTASIS MARKET 83
1.4 LIMITATIONS 85
1.5 MARKETS COVERED 86
2 MARKET SEGMENTATION 88
2.1 MARKETS COVERED 88
2.2 GEOGRAPHICAL SCOPE 89
2.3 YEARS CONSIDERED FOR THE STUDY 90
2.4 CURRENCY AND PRICING 90
2.5 DBMR TRIPOD DATA VALIDATION MODEL 91
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 94
2.7 MULTIVARIATE MODELLING 95
2.8 DBMR MARKET POSITION GRID 96
2.9 VENDOR SHARE ANALYSIS 97
2.10 MARKET END-USER COVERAGE GRID 98
2.11 SECONDARY SOURCES 99
2.12 ASSUMPTIONS 99
3 EXECUTIVE SUMMARY 100
4 PREMIUM INSIGHTS 106
4.1 PORTERS FIVE FORCES ANALYSIS 107
4.2 BRAND OUTLOOK 108
4.2.1 BRAND COMPARATIVE ANALYSIS OF KEY EUROPE PLAYERS 108
4.2.1.1 BRAND COMPARATIVE NARRATIVE (ANALYTICAL OVERVIEW) 109
4.2.2 PRODUCT VS BRAND OVERVIEW - EUROPE ENDOSCOPIC HEMOSTASIS MARKET 110
4.2.2.1 PRODUCT OVERVIEW - ENDOSCOPIC HEMOSTASIS DEVICES 110
4.2.2.2 BRAND OVERVIEW - INFLUENCE ON EUROPE CLINICAL ADOPTION 110
4.3 CONSUMER BUYING BEHAVIOUR 111
4.3.1 CLINICAL EFFECTIVENESS AND PATIENT OUTCOMES 111
4.3.2 COST AND VALUE CONSIDERATIONS 111
4.3.3 COMPATIBILITY AND INTEGRATION 111
4.3.4 TRAINING REQUIREMENTS AND EASE OF USE 111
4.3.5 REIMBURSEMENT AND HEALTHCARE POLICY ALIGNMENT 111
4.3.6 PROCUREMENT PROCESSES AND BULK AGREEMENTS 112
4.3.7 INFLUENCE OF CLINICAL STAKEHOLDERS 112
4.3.8 TRENDS IN BUYER BEHAVIOUR 112
4.3.9 CONCLUSION 112
4.4 PATENT ANALYSIS 113
4.4.1 PATENT QUALITY AND STRENGTH - EUROPE ENDOSCOPIC HEMOSTASIS MARKET 113
4.4.2 COUNTRY PATENT LANDSCAPE 113
4.4.3 IP STRATEGY AND MANAGEMENT 115
4.4.4 LICENSING AND COLLABORATION 115
4.5 RAW MATERIAL COVERAGE 117
4.5.1 METALLIC COMPONENTS AND ALLOY SYSTEMS 117
4.5.2 POLYMERIC AND SYNTHETIC MATERIALS 117
4.5.3 NATURAL AND BIOCOMPATIBLE MATERIALS 117
4.5.4 ELECTRICAL AND THERMAL MATERIAL SYSTEMS 118
4.5.5 EXPENDABLE ACCESSORIES AND SINGLE-USE MATERIALS 118
4.6 TECHNOLOGICAL ADVANCEMENTS IN EUROPE ENDOSCOPIC HEMOSTASIS MARKET 119
4.6.1 ENHANCED MECHANICAL HEMOSTASIS TOOLS 119
4.6.2 ADVANCED THERMAL COAGULATION AND ENERGY-BASED SYSTEMS 119
4.6.3 NOVEL TOPICAL HEMOSTATIC AGENTS 119
4.6.4 INTEGRATION WITH ADJUNCTIVE DIAGNOSTIC TECHNOLOGIES 119
4.6.5 DEVELOPMENT OF MULTIFUNCTIONAL AND COMBINATION DEVICES 119
4.6.6 IMPROVED USER ERGONOMICS AND DEVICE DEPLOYMENT SYSTEMS 120
4.6.7 CONCLUSION 120
4.7 VALUE CHAIN ANALYSIS 121
4.7.1 OVERVIEW 121
4.7.2 RAW MATERIALS & COMPONENTS 121
4.7.3 DEVICE DESIGN, R&D & MANUFACTURING 122
4.7.4 PROCESSING, FINISHING & STERILIZATION 122
4.7.5 PACKAGING & LABELING 122
4.7.6 LOGISTICS, DISTRIBUTION & COMMERCIALIZATION 122
4.7.7 CONCLUSION 122
4.8 VENDOR SELECTION CRITERIA 123
4.8.1 CLINICAL PERFORMANCE 123
4.8.2 REGULATORY COMPLIANCE AND APPROVALS 123
4.8.3 COST AND TOTAL VALUE PROPOSITION 123
4.8.4 SUPPLY CHAIN ROBUSTNESS AND LOGISTICS 123
4.8.5 SUPPORT, TRAINING AND CLINICAL EDUCATION 123
4.8.6 QUALITY SYSTEMS AND REPROCESSING GUIDANCE 123
4.8.7 REPUTATION, PEER ACCEPTANCE AND POST-MARKET PERFORMANCE 123
4.8.8 INNOVATION AND FUTURE-READINESS 124
4.9 COMPANY EVALUATION QUADRANT 125
4.10 PROFIT MARGIN SCENARIO 127
4.10.1 MARGIN IMPROVEMENT DRIVERS 127
4.10.2 COST PRESSURE 127
4.10.3 REGIONAL VARIATIONS 127
4.10.4 FUTURE SCENARIOS 128
4.11 CLIMATE CHANGE SCENARIO 129
4.11.1 ENVIRONMENTAL CONCERNS 129
4.11.2 INDUSTRY RESPONSE 129
4.11.3 GOVERNMENT'S ROLE 129
4.11.4 ANALYST RECOMMENDATIONS 130
4.12 INNOVATION TRACKER AND STRATEGIC ANALYSIS 131
4.12.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS 131
4.12.1.1 JOINT VENTURES 131
4.12.1.2 MERGERS AND ACQUISITIONS 131
4.12.1.3 LICENSING AND PARTNERSHIP 131
4.12.1.4 TECHNOLOGY COLLABORATIONS 131
4.12.2 STRATEGIC DIVESTMENTS 132
4.12.3 STAGE OF DEVELOPMENT 132
4.12.4 TIMELINES AND MILESTONES 132
4.12.5 INNOVATION STRATEGIES AND METHODOLOGIES 132
4.12.6 RISK ASSESSMENT AND MITIGATION 132
4.12.7 FUTURE OUTLOOK 133
4.13 PRICING ANALYSIS 134
4.13.1 HEMOSTATIC CLIPS AND FORCEPS PRICING 134
4.13.2 BANDING AND COAGULATION DEVICES 135
4.13.3 REGULATORY AND REIMBURSEMENT IMPACT 135
4.14 SUPPLY CHAIN ANALYSIS 136
4.14.1 OVERVIEW 136
4.14.2 LOGISTIC COST SCENARIO 136
4.14.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS 136
4.14.4 CONCLUSION 137
5 TARIFFS & IMPACT ON THE MARKET 138
5.1 OVERVIEW 138
5.2 CURRENT TARIFF RATE (S) IN TOP-5 COUNTRY MARKETS 138
5.3 OUTLOOK: LOCAL PRODUCTION V/S IMPORT RELIANCE 138
5.4 VENDOR SELECTION CRITERIA 139
5.5 IMPACT ON SUPPLY CHAIN 139
5.5.1 RAW MATERIAL PROCUREMENT 139
5.5.2 MANUFACTURING AND PRODUCTION 139
5.5.3 LOGISTICS AND DISTRIBUTION 139
5.5.4 PRICE PITCHING AND POSITION OF MARKET 139
5.6 INDUSTRY PARTICIPANTS: PROACTIVE MOVES 139
5.6.1 SUPPLY CHAIN OPTIMIZATION 139
5.6.2 JOINT VENTURE ESTABLISHMENTS 139
5.7 IMPACT ON PRICES 140
5.8 REGULATORY INCLINATION 140
5.8.1 GEOPOLITICAL SITUATION 140
5.8.2 TRADE PARTNERSHIPS BETWEEN THE COUNTRIES 140
5.8.2.1 FREE TRADE AGREEMENTS 140
5.8.2.2 ALLIANCES ESTABLISHMENTS 140
5.8.3 STATUS ACCREDITATION (INCLUDING MFTN) 140
5.8.4 DOMESTIC COURSE OF CORRECTION 140
5.8.4.1 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS 140
5.8.4.2 ESTABLISHMENT OF SEZS/INDUSTRIAL PARKS 140
6 REGULATION COVERAGE 141
6.1 PRODUCT CODES 141
6.2 CERTIFIED STANDARDS 141
6.3 SAFETY STANDARDS 142
6.3.1 MATERIAL HANDLING & STORAGE 142
6.3.2 TRANSPORT & PRECAUTIONS 142
6.3.3 HAZARD IDENTIFICATION 142
7 MARKET OVERVIEW 143
7.1 DRIVERS 145
7.1.1 RISE IN GASTROINTESTINAL BLEEDING CASES 145
7.1.2 AGING POPULATION DRIVING INCREASED DEMAND FOR GI DISORDERS 146
7.1.3 ADOPTION OF MINIMALLY INVASIVE ENDOSCOPIC PROCEDURES 147
7.1.4 RISING AWARENESS AND EXPANDED SCREENING PROGRAMS FOR GASTROINTESTINAL ENDOSCOPY 148
7.2 RESTRAINTS 149
7.2.1 HIGH COST AND TECHNICAL COMPLEXITY OF ENDOSCOPIC HEMOSTASIS DEVICES 149
7.2.2 LIMITED AWARENESS IN LOW-INCOME COUNTRIES 150
7.3 OPPORTUNITIES 151
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN HEMOSTASIS DEVICES 151
7.3.2 EXPANSION IN EMERGING MARKETS (ASIA-PACIFIC, LATIN AMERICA) 152
7.3.3 GROWING ADOPTION OF HOME-BASED AND CAPSULE ENDOSCOPY SOLUTIONS 153
7.4 CHALLENGES 154
7.4.1 REIMBURSEMENT ISSUES FOR ENDOSCOPIC PROCEDURES 154
7.4.2 COMPLEXITIES IN ENDOSCOPE REPROCESSING AND STERILIZATION PROCESSES 155
8 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE 156
8.1 OVERVIEW 157
8.2 MECHANICAL HEMOSTASIS DEVICES 160
8.2.1 MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 160
8.2.1.1 HEMOSTATIC CLIPS 161
8.2.1.1.1 HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE 161
8.2.1.1.1.1 THROUGH-THE-SCOPE (TTS) CLIPS 161
8.2.1.1.1.2 OVER-THE-SCOPE (OTS) CLIPS 161
8.2.1.1.2 HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL 162
8.2.1.1.2.1 STAINLESS STEEL 162
8.2.1.1.2.2 TITANIUM 162
8.2.1.2 BANDING DEVICES 163
8.2.1.2.1 BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE 163
8.2.1.2.1.1 VARICEAL BANDING KITS 163
8.2.1.2.1.2 OESOPHAGEAL BANDING DEVICES 163
8.2.1.3 HEMOSTATIC FORCEPS 163
8.2.1.4 OTHERS 163
8.2.2 MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 164
8.2.2.1 NORTH AMERICA 164
8.2.2.2 EUROPE 164
8.2.2.3 ASIA-PACIFIC 164
8.2.2.4 SOUTH AMERICA 164
8.2.2.5 MIDDLE EAST & AFRICA 164
8.3 THERMAL DEVICES 165
8.3.1 THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 165
8.3.1.1 ARGON PLASMA COAGULATORS 165
8.3.1.2 HEATER PROBES 165
8.3.1.3 BIPOLAR COAGULATION DEVICES 165
8.3.1.3.1 BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE 166
8.3.1.3.1.1 MONOPOLAR 166
8.3.1.3.1.2 BIPOLAR 166
8.3.1.3.2 BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION 167
8.3.1.3.2.1 UPPER GI BLEEDING 167
8.3.1.3.2.2 LOWER GI BLEEDING 167
8.3.1.4 OTHERS 167
8.3.2 THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 168
8.3.2.1 NORTH AMERICA 168
8.3.2.2 EUROPE 168
8.3.2.3 ASIA-PACIFIC 168
8.3.2.4 SOUTH AMERICA 168
8.3.2.5 MIDDLE EAST & AFRICA 168
8.4 TOPICAL AGENTS AND INJECTABLES 169
8.4.1 TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 169
8.4.1.1 EPINEPHRINE INJECTION 169
8.4.1.2 HEMOSTATIC SPRAY (POWDER) 169
8.4.1.3 HEMOSTATIC GELS 169
8.4.1.4 FIBRIN SEALANTS 170
8.4.1.5 SCLEROSING AGENTS 170
8.4.2 TOPICAL AGENTS AND INJECTABLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 170
8.4.2.1 NORTH AMERICA 170
8.4.2.2 EUROPE 170
8.4.2.3 ASIA-PACIFIC 170
8.4.2.4 SOUTH AMERICA 171
8.4.2.5 MIDDLE EAST & AFRICA 171
8.5 OTHERS 171
8.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 171
8.5.1.1 NORTH AMERICA 171
8.5.1.2 EUROPE 171
8.5.1.3 ASIA-PACIFIC 172
8.5.1.4 SOUTH AMERICA 172
8.5.1.5 MIDDLE EAST & AFRICA 172
9 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE TYPE 173
9.1 OVERVIEW 174
9.2 UPPER GASTROINTESTINAL ENDOSCOPY 176
9.2.1 UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 176
9.2.1.1 BLEEDING ULCER MANAGEMENT 177
9.2.1.2 VARICEAL BLEEDING 177
9.2.1.3 DIEULAFOY LESION 177
9.2.2 UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 177
9.2.2.1 NORTH AMERICA 177
9.2.2.2 EUROPE 177
9.2.2.3 ASIA-PACIFIC 178
9.2.2.4 SOUTH AMERICA 178
9.2.2.5 MIDDLE EAST & AFRICA 178
9.3 LOWER GASTROINTESTINAL ENDOSCOPY 178
9.3.1 LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 178
9.3.1.1 COLONIC BLEEDING 178
9.3.1.2 DIVERTICULAR BLEEDING 179
9.3.2 LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 179
9.3.2.1 NORTH AMERICA 179
9.3.2.2 EUROPE 179
9.3.2.3 ASIA-PACIFIC 179
9.3.2.4 SOUTH AMERICA 179
9.3.2.5 MIDDLE EAST & AFRICA 180
9.4 BRONCHOSCOPIC HEMOSTASIS 180
9.4.1 BRONCHOSCOPIC HEMOSTASIS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 180
9.4.1.1 NORTH AMERICA 180
9.4.1.2 EUROPE 180
9.4.1.3 ASIA-PACIFIC 180
9.4.1.4 SOUTH AMERICA 181
9.4.1.5 MIDDLE EAST & AFRICA 181
9.5 OTHERS 181
9.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 181
9.5.1.1 NORTH AMERICA 181
9.5.1.2 EUROPE 181
9.5.1.3 ASIA-PACIFIC 182
9.5.1.4 SOUTH AMERICA 182
9.5.1.5 MIDDLE EAST & AFRICA 182
10 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION 183
10.1 OVERVIEW 184
10.2 GASTROINTESTINAL BLEEDING 187
10.2.1 GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 187
10.2.1.1 PEPTIC ULCER BLEEDING 188
10.2.1.2 ESOPHAGEAL VARICES 188
10.2.1.3 COLORECTAL CANCERS 188
10.2.2 GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE 188
10.2.2.1 MECHANICAL HEMOSTASIS DEVICES 188
10.2.2.2 THERMAL DEVICES 189
10.2.2.3 TOPICAL AGENTS AND INJECTABLES 189
10.2.2.4 OTHERS 189
10.2.3 GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 189
10.2.3.1 NORTH AMERICA 189
10.2.3.2 EUROPE 189
10.2.3.3 ASIA-PACIFIC 190
10.2.3.4 SOUTH AMERICA 190
10.2.3.5 MIDDLE EAST & AFRICA 190
10.3 NON-GASTROINTESTINAL BLEEDING 190
10.3.1 NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 190
10.3.1.1 NASAL BLEEDING (EPISTAXIS) 190
10.3.1.2 POST-SURGICAL BLEEDING 191
10.3.2 NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE 191
10.3.2.1 MECHANICAL HEMOSTASIS DEVICES 191
10.3.2.2 THERMAL DEVICES 191
10.3.2.3 TOPICAL AGENTS & INJECTABLES 191
10.3.2.4 OTHERS 192
10.3.3 NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND) 192
10.3.3.1 NORTH AMERICA 192
10.3.3.2 EUROPE 192
10.3.3.3 ASIA-PACIFIC 192
10.3.3.4 SOUTH AMERICA 192
10.3.3.5 MIDDLE EAST & AFRICA 193
10.4 TRAUMA MANAGEMENT 193
10.4.1 TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE 193
10.4.1.1 MECHANICAL HEMOSTASIS DEVICES 193
10.4.1.2 THERMAL DEVICES 193
10.4.1.3 TOPICAL AGENTS & INJECTABLES 194
10.4.1.4 OTHERS 194
10.4.2 TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 194
10.4.2.1 NORTH AMERICA 194
10.4.2.2 EUROPE 194
10.4.2.3 ASIA-PACIFIC 194
10.4.2.4 SOUTH AMERICA 195
10.4.2.5 MIDDLE EAST & AFRICA 195
10.5 OTHERS 195
10.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 195
10.5.1.1 NORTH AMERICA 195
10.5.1.2 EUROPE 195
10.5.1.3 ASIA-PACIFIC 196
10.5.1.4 SOUTH AMERICA 196
10.5.1.5 MIDDLE EAST & AFRICA 196
11 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY END USER 197
11.1 OVERVIEW 198
11.2 HOSPITALS 201
11.2.1 HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 201
11.2.1.1 PUBLIC 201
11.2.1.2 PRIVATE 201
11.2.2 HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 202
11.2.2.1 NORTH AMERICA 202
11.2.2.2 EUROPE 202
11.2.2.3 ASIA-PACIFIC 202
11.2.2.4 SOUTH AMERICA 202
11.2.2.5 MIDDLE EAST & AFRICA 202
11.3 AMBULATORY SURGERY CENTERS 203
11.3.1 AMBULATORY SURGERY CENTERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 203
11.3.1.1 NORTH AMERICA 203
11.3.1.2 EUROPE 203
11.3.1.3 ASIA-PACIFIC 203
11.3.1.4 SOUTH AMERICA 203
11.3.1.5 MIDDLE EAST & AFRICA 204
11.4 SPECIALTY CLINICS 204
11.4.1 SPECIALTY CLINICS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 204
11.4.1.1 NORTH AMERICA 204
11.4.1.2 EUROPE 204
11.4.1.3 ASIA-PACIFIC 204
11.4.1.4 SOUTH AMERICA 205
11.4.1.5 MIDDLE EAST & AFRICA 205
11.5 OTHERS 205
11.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 205
11.5.1.1 NORTH AMERICA 205
11.5.1.2 EUROPE 205
11.5.1.3 ASIA-PACIFIC 206
11.5.1.4 SOUTH AMERICA 206
11.5.1.5 MIDDLE EAST & AFRICA 206
12 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL 207
12.1 OVERVIEW 208
12.2 INDIRECT SALES 211
12.2.1 INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE 211
12.2.1.1 OFFLINE 211
12.2.1.2 ONLINE 211
12.2.2 INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 212
12.2.2.1 NORTH AMERICA 212
12.2.2.2 EUROPE 212
12.2.2.3 ASIA-PACIFIC 212
12.2.2.4 SOUTH AMERICA 212
12.2.2.5 MIDDLE EAST & AFRICA 212
12.3 DIRECT SALES 213
12.3.1 DIRECT SALES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 213
12.3.1.1 NORTH AMERICA 213
12.3.1.2 EUROPE 213
12.3.1.3 ASIA-PACIFIC 213
12.3.1.4 SOUTH AMERICA 213
12.3.1.5 MIDDLE EAST & AFRICA 214
13 EUROPE ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 215
13.1 EUROPE 217
13.1.1 GERMANY 228
13.1.2 U.K. 238
13.1.3 FRANCE 248
13.1.4 ITALY 258
13.1.5 SPAIN 268
13.1.6 NETHERLANDS 278
13.1.7 BELGIUM 288
13.1.8 SWITZERLAND 298
13.1.9 SWEDEN 308
13.1.10 DENMARK 318
13.1.11 NORWAY 328
13.1.12 FINLAND 337
13.1.13 RUSSIA 347
13.1.14 TURKEY 356
13.1.15 REST OF EUROPE 366
14 EUROPE ENDOSCOPIC HEMOSTASIS MARKET: COMPANY LANDSCAPE 376
14.1 COMPANY SHARE ANALYSIS: GLOBAL 376
15 SWOT ANALYSIS 377
16 COMPANY PROFILES MANUFACTURERS 378
16.1 OLYMPUS CORPORATION 378
16.1.1 COMPANY SNAPSHOT 378
16.1.2 REVENUE ANALYSIS 378
16.1.3 COMPANY SHARE ANALYSIS 379
16.1.4 PRODUCT PORTFOLIO 379
16.1.5 RECENT DEVELOPMENT 380
16.2 BOSTON SCIENTIFIC CORPORATION 381
16.2.1 COMPANY SNAPSHOT 381
16.2.2 REVENUE ANALYSIS 381
16.2.3 COMPANY SHARE ANALYSIS 382
16.2.4 PRODUCT PORTFOLIO 382
16.2.5 RECENT DEVELOPMENT 383
16.3 CONMED CORPORATION 384
16.3.1 COMPANY SNAPSHOT 384
16.3.2 REVENUE ANALYSIS 384
16.3.3 COMPANY SHARE ANALYSIS 385
16.3.4 PRODUCT PORTFOLIO 385
16.3.5 RECENT DEVELOPMENT 386
16.4 MEDTRONIC 387
16.4.1 COMPANY SNAPSHOT 387
16.4.2 REVENUE ANALYSIS 387
16.4.3 COMPANY SHARE ANALYSIS 388
16.4.4 PRODUCT PORTFOLIO 388
16.4.5 RECENT DEVELOPMENT 389
16.5 COOK 390
16.5.1 COMPANY SNAPSHOT 390
16.5.2 COMPANY SHARE ANALYSIS 390
16.5.3 PRODUCT PORTFOLIO 391
16.5.4 RECENT DEVELOPMENT 392
16.6 ANKAFERD 393
16.6.1 COMPANY SNAPSHOT 393
16.6.2 PRODUCT PORTFOLIO 393
16.6.3 RECENT DEVEOPMENT 394
16.7 B. BRAUN SE 395
16.7.1 COMPANY SNAPSHOT 395
16.7.2 PRODUCT PORTFOLIO 395
16.7.3 RECENT DEVEOPMENT 395
16.8 CREO MEDICAL GMBH 396
16.8.1 COMPANY SNAPSHOT 396
16.8.2 PRODUCT PORTFOLIO 396
16.8.3 RECENT DEVELOPMENT 396
16.9 DIVERSATEK, INC. 397
16.9.1 COMPANY SNAPSHOT 397
16.9.2 PRODUCT PORTFOLIO 397
16.9.3 RECENT DEVEOPMENT 397
16.10 DUOMED GROUP 398
16.10.1 COMPANY SNAPSHOT 398
16.10.2 PRODUCT PORTFOLIO 398
16.10.3 RECENT DEVEOPMENT 399
16.11 ENDOCLOT PLUS, INC. 400
16.11.1 COMPANY SNAPSHOT 400
16.11.2 PRODUCT PORTFOLIO 400
16.11.3 RECENT DEVEOPMENT 401
16.12 ERBE ELEKTROMEDIZIN GMBH 402
16.12.1 COMPANY SNAPSHOT 402
16.12.2 PRODUCT PORTFOLIO 402
16.12.3 RECENT DEVELOPMENT 403
16.13 FUJIFILM HOLDINGS CORPORATION 404
16.13.1 COMPANY SNAPSHOT 404
16.13.2 REVENUE ANALYSIS 404
16.13.3 PRODUCT PORTFOLIO 405
16.13.4 RECENT DEVELOPMENT 409
16.14 JOHNSON & JOHNSON (ETHICON) 410
16.14.1 COMPANY SNAPSHOT 410
16.14.2 REVENUE ANALYSIS 410
16.14.3 PRODUCT PORTFOLIO 411
16.14.4 RECENT DEVEOPMENT 412
16.15 KARL STORZ SE & CO. KG, TUTTLINGEN 413
16.15.1 COMPANY SNAPSHOT 413
16.15.2 PRODUCT PORTFOLIO 413
16.15.3 RECENT DEVEOPMENT 413
16.16 MEDITALIA S.R.L. 414
16.16.1 COMPANY SNAPSHOT 414
16.16.2 PRODUCT PORTFOLIO 414
16.16.3 RECENT DEVELOPMENT 415
16.17 MICRO-TECH ENDOSCOPY 416
16.17.1 COMPANY SNAPSHOT 416
16.17.2 PRODUCT PORTFOLIO 416
16.17.3 RECENT DEVELOPMENT 417
16.18 MTW ENDOSKOPIE MANUFAKTU 418
16.18.1 COMPANY SNAPSHOT 418
16.18.2 PRODUCT PORTFOLIO 418
16.18.3 RECENT DEVEOPMENT 418
16.19 OVESCO ENDOSCOPY AG 419
16.19.1 COMPANY SNAPSHOT 419
16.19.2 PRODUCT PORTFOLIO 419
16.19.3 RECENT DEVEOPMENT 420
16.20 PENTAX MEDICAL 421
16.20.1 COMPANY SNAPSHOT 421
16.20.2 SOLUTION PORTFOLIO 421
16.20.3 RECENT DEVELOPMENT 421
16.21 STERIS 422
16.21.1 COMPANY SNAPSHOT 422
16.21.2 REVENUE ANALYSIS 422
16.21.3 PRODUCT PORTFOLIO 423
16.21.4 RECENT DEVELOPMENT 426
17 COMPANY PROFILES DISTRIBUTOR 427
17.1 BOSTON IVY HEALTHCARE SOLUTIONS PRIVATE LIMITED 427
17.1.1 COMPANY SNAPSHOT 427
17.1.2 PRODUCT PORTFOLIO 427
17.1.3 RECENT DEVELOPMENT 427
17.2 CARDINAL HEALTH 428
17.2.1 COMPANY SNAPSHOT 428
17.2.2 REVENUE ANALYSIS 428
17.2.3 PRODUCT PORTFOLIO 429
17.2.4 RECENT DEVEOPMENT 429
17.3 HENRY SCHEIN, INC. 430
17.3.1 COMPANY SNAPSHOT 430
17.3.2 REVENUE ANALYSIS 430
17.3.3 PRODUCT PORTFOLIO 431
17.3.4 RECENT DEVEOPMENT 431
17.4 MCKESSON MEDICAL-SURGICAL INC. 432
17.4.1 COMPANY SNAPSHOT 432
17.4.2 PRODUCT PORTFOLIO 432
17.4.3 RECENT DEVEOPMENT 433
17.5 MFI MEDICAL 434
17.5.1 COMPANY SNAPSHOT 434
17.5.2 PRODUCT PORTFOLIO 434
17.5.3 RECENT DEVEOPMENT 434
18 QUESTIONNAIRE 435
19 RELATED REPORTS 438
?